Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 43: 1306-1310, 1997;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (15)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McNamara, J. R.
Right arrow Articles by Cooper, G. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McNamara, J. R.
Right arrow Articles by Cooper, G. R.
Related Collections
Right arrow Laboratory Management
Right arrow Lipids, Lipoproteins, and Cardiovascular Risk Factors
(Clinical Chemistry. 1997;43:1306-1310.)
© 1997 American Association for Clinical Chemistry, Inc.


Articles

Point Status of lipid and lipoprotein standardization

Judith R. McNamara1,a, Elizabeth Teng Leary2, Ferruccio Ceriotti3, Christa M. Boersma-Cobbaert4, Thomas G. Cole5, David J. Hassemer6, Masakazu Nakamura7, Christopher J. Packard8, David W. Seccombe9, Mary M. Kimberly10, Gary L. Myers10 and Gerald R. Cooper10

1 Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, 711 Washington St., Boston, MA 02111.

2 Pacific Biometrics Research Foundation, Seattle, WA.

3 H.S. Raffaele, Milan, Italy.

4 Rotterdam University Hospital, Rotterdam, The Netherlands.

5 Washington University School of Medicine, St. Louis, MO.

6 State Laboratory of Hygiene, Madison, WI.

7 Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan.

8 Institute of Biochemistry, Glasgow Royal Infirmary, Glasgow, Scotland, UK.

9 Canadian Reference Laboratory (1996) Ltd., Vancouver, BC, Canada.

10 Centers for Disease Control and Prevention, Atlanta, GA.
a Author for correspondence. Fax 617-556-3103;

Cholesterol and triglyceride standardization procedures have been used extensively and continuously since the 1950s. Definitive and Reference Methods, as well as primary and secondary standards, have been developed and maintained as the basis for evaluating the accuracy of results by various methods in many laboratories. But, although standardization efforts for apolipoprotein A-I and B measurements have been reported in detail in the scientific literature, much less has been reported in the area of total and lipoprotein cholesterol and triglyceride standardization efforts. Standardized cholesterol and triglyceride concentrations, determined in multiple large epidemiological and clinical studies, have been instrumental to the National Cholesterol Education Program panels that have assessed the lipoprotein values associated with risk of coronary disease, and have determined the cutpoints that are now used extensively by physicians to guide diagnosis and treatment of individual patients.




The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
L. M. Thienpont, K. Van Uytfanghe, J. Marriott, P. Stokes, L. Siekmann, A. Kessler, D. Bunk, and S. Tai
Feasibility Study of the Use of Frozen Human Sera in Split-Sample Comparison of Immunoassays with Candidate Reference Measurement Procedures for Total Thyroxine and Total Triiodothyronine Measurements
Clin. Chem., December 1, 2005; 51(12): 2303 - 2311.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
L. M. Thienpont, K. Van Uytfanghe, J. Marriot, P. Stokes, L. Siekmann, A. Kessler, D. Bunk, and S. Tai
Metrologic Traceability of Total Thyroxine Measurements in Human Serum: Efforts to Establish a Network of Reference Measurement Laboratories
Clin. Chem., January 1, 2005; 51(1): 161 - 168.
[Abstract] [Full Text] [PDF]


Home page
British Journal of Diabetes & Vascular DiseaseHome page
W. Richmond
When and how to measure lipids and their role in CHD risk prediction
The British Journal of Diabetes & Vascular Disease, May 1, 2003; 3(3): 191 - 198.
[Abstract] [PDF]


Home page
Clin. Chem.Home page
C. Cobbaert, C. Weykamp, H. Baadenhuijsen, A. Kuypers, J. Lindemans, and R. Jansen
Selection, Preparation, and Characterization of Commutable Frozen Human Serum Pools as Potential Secondary Reference Materials for Lipid and Apolipoprotein Measurements: Study within the Framework of the Dutch Project "Calibration 2000"
Clin. Chem., September 1, 2002; 48(9): 1526 - 1538.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
C. M. Cobbaert and T. K. J. Luderer
Total Error Evaluation of Roche Direct HDL-Cholesterol Reagent and Calibrator across 31 Lot Combinations: A 2-Year Experience
Clin. Chem., January 1, 2000; 46(1): 133 - 134.
[Full Text] [PDF]


Home page
J. Lipid Res.Home page
A. Schlenck, B. Herbeth, G. Siest, and S. Visvikis
Characterization and quantification of serum lipoprotein subfractions by capillary isotachophoresis: relationships with lipid, apolipoprotein, and lipoprotein levels
J. Lipid Res., November 1, 1999; 40(11): 2125 - 2133.
[Abstract] [Full Text]


Home page
Clin. Chem.Home page
C. Cobbaert, P. G.H. Mulder, H. Baadenhuijsen, L. Zwang, C. W. Weykamp, and P. N.M. Demacker
Survey of Total Error of Precipitation and Homogeneous HDL-Cholesterol Methods and Simultaneous Evaluation of Lyophilized Saccharose-containing Candidate Reference Materials for HDL-Cholesterol
Clin. Chem., March 1, 1999; 45(3): 360 - 370.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American Association for Clinical Chemistry.